Pessimistic 发表于 2025-3-21 19:32:22

书目名称Ovarian Cancer Biomarkers影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0705202<br><br>        <br><br>书目名称Ovarian Cancer Biomarkers读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0705202<br><br>        <br><br>

eulogize 发表于 2025-3-21 21:51:24

http://reply.papertrans.cn/71/7053/705202/705202_2.png

Devastate 发表于 2025-3-22 02:32:44

http://reply.papertrans.cn/71/7053/705202/705202_3.png

Communicate 发表于 2025-3-22 04:56:33

http://reply.papertrans.cn/71/7053/705202/705202_4.png

头盔 发表于 2025-3-22 11:35:01

Book 2021ling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmark

Bph773 发表于 2025-3-22 13:25:09

http://reply.papertrans.cn/71/7053/705202/705202_6.png

Mutter 发表于 2025-3-22 20:26:54

Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response a of the solid cancers that have benefited from genetic biomarkers for the implementation of targeted agents such as PARP inhibitors in clinical practice. This progress is discussed in this chapter based on recent studies and clinical trials.

Obstruction 发表于 2025-3-22 23:17:59

Cutting-Edge Technologies for Ovarian Cancer: An Overview of the Impact of Genetic Testing, Next-Gepact on patients’ outcomes according to the latest research findings. We finally depict the potential of single-cell sequencing in understanding OC heterogeneity based on recent proof-of-concept studies.

侵略者 发表于 2025-3-23 03:13:19

http://reply.papertrans.cn/71/7053/705202/705202_9.png

ASTER 发表于 2025-3-23 05:36:33

The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkerinatorial approaches. In this chapter, the clinical impact of genetics, biomarkers, and therapy in OC is reviewed based on the hallmarks of cancer. We particularly present a special emphasis on druggable targets investigated in phase II/III clinical trials for OC.
页: [1] 2 3 4 5
查看完整版本: Titlebook: Ovarian Cancer Biomarkers; Mapping to Improve O Khalid El Bairi Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusive